e-Therapeutics Starts Phase IIb Trial of ETS6103 in Major Depressive Disorder

I simply needed to put this publish out. I believe it’s pretty awesome. It might not be quite around the subject of the blog, however think it certainly is helpful to see round the subject.

e-Therapeutics plc announces that it has started a randomised double-blind controlled phase IIb trial of ETS6103 in major depressive disorder. The trial is evaluating ETS6103 as a second-line treatment for patients who have not responded adequately to first-line therapy with an SSRI ….e-Therapeutics Starts Phase IIb Trial of ETS6103 in Major Depressive Disorder

Now you’ve been through that, here below are a handful of links with other pages which i think you might find helpful. Possess a quick overview of them they might be what you are searching for, however only you will be aware that.

Below are a few additional blogposts on the issue of depression treatment therapy

Leave a comment